{"id":"https://openalex.org/W2215818478","doi":"https://doi.org/10.1016/j.jconrel.2015.12.019","title":"Generation of a double transgenic humanized neonatal Fc receptor (FcRn)/albumin mouse to study the pharmacokinetics of albumin-linked drugs","display_name":"Generation of a double transgenic humanized neonatal Fc receptor (FcRn)/albumin mouse to study the pharmacokinetics of albumin-linked drugs","publication_year":2015,"publication_date":"2015-12-17","ids":{"openalex":"https://openalex.org/W2215818478","doi":"https://doi.org/10.1016/j.jconrel.2015.12.019","mag":"2215818478","pmid":"https://pubmed.ncbi.nlm.nih.gov/26699424"},"language":"en","primary_location":{"id":"doi:10.1016/j.jconrel.2015.12.019","doi":"https://doi.org/10.1016/j.jconrel.2015.12.019","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2015.12.019","pdf_url":null,"source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087682286","display_name":"Dorthe Viuff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I106887733","display_name":"Novozymes (Denmark)","ror":"https://ror.org/03ejz0s07","country_code":"DK","type":"company","lineage":["https://openalex.org/I106887733","https://openalex.org/I2801134892","https://openalex.org/I4210159963","https://openalex.org/I4405271692"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Dorthe Viuff","raw_affiliation_strings":["Novozymes Biopharma, Novozymes A/S, Brudelysvej 32, 2880 Bagsv\u00e6rd, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novozymes Biopharma, Novozymes A/S, Brudelysvej 32, 2880 Bagsv\u00e6rd, Denmark","institution_ids":["https://openalex.org/I106887733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067411479","display_name":"Filipa Antunes","orcid":"https://orcid.org/0000-0002-8472-078X","observed_orcids":["https://orcid.org/0000-0002-8472-078X"]},"institutions":[{"id":"https://openalex.org/I4210092287","display_name":"Novozymes (United Kingdom)","ror":"https://ror.org/00nat9r59","country_code":"GB","type":"company","lineage":["https://openalex.org/I2801134892","https://openalex.org/I4210092287","https://openalex.org/I4210159963","https://openalex.org/I4405271692"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Filipa Antunes","raw_affiliation_strings":["Novozymes Biopharma UK Ltd., Castle Court, 59 Castle Boulevard, NG7 1FD Nottingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novozymes Biopharma UK Ltd., Castle Court, 59 Castle Boulevard, NG7 1FD Nottingham, United Kingdom","institution_ids":["https://openalex.org/I4210092287"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080786001","display_name":"Leslie R. Evans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092287","display_name":"Novozymes (United Kingdom)","ror":"https://ror.org/00nat9r59","country_code":"GB","type":"company","lineage":["https://openalex.org/I2801134892","https://openalex.org/I4210092287","https://openalex.org/I4210159963","https://openalex.org/I4405271692"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Leslie Evans","raw_affiliation_strings":["Novozymes Biopharma UK Ltd., Castle Court, 59 Castle Boulevard, NG7 1FD Nottingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novozymes Biopharma UK Ltd., Castle Court, 59 Castle Boulevard, NG7 1FD Nottingham, United Kingdom","institution_ids":["https://openalex.org/I4210092287"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066208967","display_name":"Jason Cameron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092287","display_name":"Novozymes (United Kingdom)","ror":"https://ror.org/00nat9r59","country_code":"GB","type":"company","lineage":["https://openalex.org/I2801134892","https://openalex.org/I4210092287","https://openalex.org/I4210159963","https://openalex.org/I4405271692"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jason Cameron","raw_affiliation_strings":["Novozymes Biopharma UK Ltd., Castle Court, 59 Castle Boulevard, NG7 1FD Nottingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novozymes Biopharma UK Ltd., Castle Court, 59 Castle Boulevard, NG7 1FD Nottingham, United Kingdom","institution_ids":["https://openalex.org/I4210092287"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072972207","display_name":"Hans Dyrnesli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204337017","display_name":"Aarhus University","ror":"https://ror.org/01aj84f44","country_code":"DK","type":"education","lineage":["https://openalex.org/I204337017"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Hans Dyrnesli","raw_affiliation_strings":["Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus C, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus C, Denmark","institution_ids":["https://openalex.org/I204337017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052012261","display_name":"Birgitte Thue Ravn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I106887733","display_name":"Novozymes (Denmark)","ror":"https://ror.org/03ejz0s07","country_code":"DK","type":"company","lineage":["https://openalex.org/I106887733","https://openalex.org/I2801134892","https://openalex.org/I4210159963","https://openalex.org/I4405271692"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Birgitte Thue Ravn","raw_affiliation_strings":["Novozymes Biopharma, Novozymes A/S, Brudelysvej 32, 2880 Bagsv\u00e6rd, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novozymes Biopharma, Novozymes A/S, Brudelysvej 32, 2880 Bagsv\u00e6rd, Denmark","institution_ids":["https://openalex.org/I106887733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030626300","display_name":"Magnus Stougaard","orcid":"https://orcid.org/0000-0001-7456-902X","observed_orcids":["https://orcid.org/0000-0001-7456-902X"]},"institutions":[{"id":"https://openalex.org/I2802335433","display_name":"Aarhus University Hospital","ror":"https://ror.org/040r8fr65","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802335433"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Magnus Stougaard","raw_affiliation_strings":["Pathology Institute, Aarhus University Hospital, 8000 Aarhus C, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology Institute, Aarhus University Hospital, 8000 Aarhus C, Denmark","institution_ids":["https://openalex.org/I2802335433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043201177","display_name":"Kader Thiam","orcid":"https://orcid.org/0009-0004-2480-5249","observed_orcids":["https://orcid.org/0009-0004-2480-5249"]},"institutions":[{"id":"https://openalex.org/I4210100708","display_name":"Genoway (France)","ror":"https://ror.org/017r9q421","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210100708"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Kader Thiam","raw_affiliation_strings":["genOway, 69362, Lyon, Cedex 07, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"genOway, 69362, Lyon, Cedex 07, France","institution_ids":["https://openalex.org/I4210100708"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102840942","display_name":"Birgitte Andersen","orcid":"https://orcid.org/0000-0003-1423-6797","observed_orcids":["https://orcid.org/0000-0003-1423-6797"]},"institutions":[{"id":"https://openalex.org/I106887733","display_name":"Novozymes (Denmark)","ror":"https://ror.org/03ejz0s07","country_code":"DK","type":"company","lineage":["https://openalex.org/I106887733","https://openalex.org/I2801134892","https://openalex.org/I4210159963","https://openalex.org/I4405271692"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Birgitte Andersen","raw_affiliation_strings":["Novozymes Biopharma, Novozymes A/S, Brudelysvej 32, 2880 Bagsv\u00e6rd, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novozymes Biopharma, Novozymes A/S, Brudelysvej 32, 2880 Bagsv\u00e6rd, Denmark","institution_ids":["https://openalex.org/I106887733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045394444","display_name":"S\u00f8ren Kj\u00e6rulff","orcid":"https://orcid.org/0000-0002-3580-4581","observed_orcids":["https://orcid.org/0000-0002-3580-4581"]},"institutions":[{"id":"https://openalex.org/I106887733","display_name":"Novozymes (Denmark)","ror":"https://ror.org/03ejz0s07","country_code":"DK","type":"company","lineage":["https://openalex.org/I106887733","https://openalex.org/I2801134892","https://openalex.org/I4210159963","https://openalex.org/I4405271692"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"S\u00f8ren Kj\u00e6rulff","raw_affiliation_strings":["Novozymes Biopharma, Novozymes A/S, Brudelysvej 32, 2880 Bagsv\u00e6rd, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novozymes Biopharma, Novozymes A/S, Brudelysvej 32, 2880 Bagsv\u00e6rd, Denmark","institution_ids":["https://openalex.org/I106887733"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049524766","display_name":"Kenneth Alan Howard","orcid":"https://orcid.org/0000-0002-9407-278X","observed_orcids":["https://orcid.org/0000-0002-9407-278X"]},"institutions":[{"id":"https://openalex.org/I204337017","display_name":"Aarhus University","ror":"https://ror.org/01aj84f44","country_code":"DK","type":"education","lineage":["https://openalex.org/I204337017"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"Kenneth A. Howard","raw_affiliation_strings":["Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus C, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Interdisciplinary Nanoscience Center (iNANO), Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus C, Denmark","institution_ids":["https://openalex.org/I204337017"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5049524766"],"corresponding_institution_ids":["https://openalex.org/I204337017"],"apc_list":{"value":4440,"currency":"USD","value_usd":4440},"apc_paid":null,"fwci":1.2691,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":{"value":0.79093741,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"223","issue":null,"first_page":"22","last_page":"30"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":0.4569999873638153,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":0.4569999873638153,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.444599986076355,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.01679999940097332,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fcrn","display_name":"neonatal Fc receptor","score":0.9490000009536743},{"id":"https://openalex.org/keywords/human-serum-albumin","display_name":"human serum albumin","score":0.949999988079071},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8709999918937683},{"id":"https://openalex.org/keywords/drug-carriers","display_name":"drug carriers","score":0.49399998784065247},{"id":"https://openalex.org/keywords/rodent-models","display_name":"rodent models","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C2780649865","wikidata":"https://www.wikidata.org/wiki/Q21101413","display_name":"Neonatal Fc receptor","level":4,"score":0.8977481126785278},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7506548166275024},{"id":"https://openalex.org/C2776125364","wikidata":"https://www.wikidata.org/wiki/Q169219","display_name":"Albumin","level":2,"score":0.6582003831863403},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.5437416434288025},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5311195850372314},{"id":"https://openalex.org/C2776156784","wikidata":"https://www.wikidata.org/wiki/Q3491954","display_name":"Humanized mouse","level":3,"score":0.45251867175102234},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.42980024218559265},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.419277548789978},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3589567542076111},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21478691697120667},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1788894534111023},{"id":"https://openalex.org/C2780898057","wikidata":"https://www.wikidata.org/wiki/Q79448","display_name":"Immunoglobulin G","level":3,"score":0.15016156435012817},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1498900055885315},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10467246174812317},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007413","descriptor_name":"Intestinal Mucosa","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008168","descriptor_name":"Lung","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011961","descriptor_name":"Receptors, Fc","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D011961","descriptor_name":"Receptors, Fc","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012709","descriptor_name":"Serum Albumin","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D012709","descriptor_name":"Serum Albumin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.jconrel.2015.12.019","doi":"https://doi.org/10.1016/j.jconrel.2015.12.019","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2015.12.019","pdf_url":null,"source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},{"id":"pmid:26699424","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26699424","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of controlled release : official journal of the Controlled Release Society","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:publications/4a3bf070-cd94-4f37-8581-0a6f2855f508","doi":null,"is_oa":false,"landing_page_url":"https://www.scopus.com/pages/publications/84955487504","pdf_url":null,"source":{"id":"https://openalex.org/S4306400063","display_name":"Scopus (Elsevier)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Viuff, D, Antunes, F, Evans, L, Cameron, J, Dyrnesli, H, Ravn, B T, Stougaard, M, Thiam, K, Andersen, B, Kj\u00e6rulff, S & Howard, K 2016, 'Generation of a Double Transgenic Humanised Neonatal Fc Receptor (FcRn)/Albumin Mouse to Study the Pharmacokinetics of Albumin-linked Drugs', Journal of Controlled Release, vol. 223, pp. 22-30. https://doi.org/10.1016/j.jconrel.2015.12.019","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309929","display_name":"Aarhus Universitetshospital","ror":"https://ror.org/040r8fr65"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1566111314","https://openalex.org/W1570348606","https://openalex.org/W1686249017","https://openalex.org/W1963563607","https://openalex.org/W1968128233","https://openalex.org/W1969070105","https://openalex.org/W1972018125","https://openalex.org/W1975687628","https://openalex.org/W1984335567","https://openalex.org/W1985912468","https://openalex.org/W2011590223","https://openalex.org/W2035776098","https://openalex.org/W2043491820","https://openalex.org/W2067258739","https://openalex.org/W2069978926","https://openalex.org/W2071843728","https://openalex.org/W2075689961","https://openalex.org/W2078923880","https://openalex.org/W2080047316","https://openalex.org/W2087166703","https://openalex.org/W2088696708","https://openalex.org/W2088900329","https://openalex.org/W2089966415","https://openalex.org/W2094347840","https://openalex.org/W2126339873","https://openalex.org/W2127401827","https://openalex.org/W2132094154","https://openalex.org/W2144536924","https://openalex.org/W2171136826","https://openalex.org/W2330359364"],"related_works":["https://openalex.org/W2397358483","https://openalex.org/W2783332803","https://openalex.org/W2244341453","https://openalex.org/W1982267707","https://openalex.org/W1963563607","https://openalex.org/W1563021253","https://openalex.org/W3185964370","https://openalex.org/W4404052922","https://openalex.org/W2906697612","https://openalex.org/W2894079764"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}